NCT06965673 Assessment of Eye Movements in Stroke Patients and Closed-loop Intervention
| NCT ID | NCT06965673 |
| Status | Recruiting |
| Phase | — |
| Sponsor | IRCCS San Camillo, Venezia, Italy |
| Condition | Stroke |
| Study Type | INTERVENTIONAL |
| Enrollment | 30 participants |
| Start Date | 2023-04-01 |
| Primary Completion | 2025-06 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 30 participants in total. It began in 2023-04-01 with a primary completion date of 2025-06.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The current study evaluates first the assumption that eye-movements during free viewing behavior are potential biomarkers of visuospatial deficits in stroke population. Second, it assesses the feasibility of a novel visual exploration training to ameliorate visuospatial deficits, by exploiting an auditory biofeedback system coupled with online parsed fixations.
Eligibility Criteria
Inclusion Criteria: * Vigilant * First unifocal ischemic or hemorragic stroke * Presence of maximum two lacunae, clinically silent, smaller than 15 mm. in the structural MRI * Evident symptoms in the visual, attentive, memory, motor or language domain supported by the radiological exam Exclusion Criteria: * Previous stroke history, visible at the radiological exam * Multifocal deficit * Incapacity to remain vigilant during the required assessments * Claustrophobia and/or metallic objects which could prevent MRI acquisition * Presence of other neurological, psychiatric or medical conditions which may undermine interpretation of behavioral and neuroimaging results
Contact & Investigator
Marco Zorzi
PRINCIPAL INVESTIGATOR
San Camillo IRCCS, Venice, Italy
Frequently Asked Questions
Who can join the NCT06965673 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Stroke. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06965673 currently recruiting?
Yes, NCT06965673 is actively recruiting participants. Contact the research team at marco.zorzi@unipd.it for enrollment information.
Where is the NCT06965673 trial being conducted?
This trial is being conducted at Padova, Italy, Venice-Lido, Italy.
Who is sponsoring the NCT06965673 clinical trial?
NCT06965673 is sponsored by IRCCS San Camillo, Venezia, Italy. The principal investigator is Marco Zorzi at San Camillo IRCCS, Venice, Italy. The trial plans to enroll 30 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.